INT245860

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.42
First Reported 2008
Last Reported 2011
Negated 0
Speculated 0
Reported most in Body
Documents 8
Total Number 15
Disease Relevance 5.37
Pain Relevance 0.19

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell adhesion (Itgb1) plasma membrane (Itgb1)
Anatomy Link Frequency
extracellular matrix 1
endothelium 1
upper 1
Itgb1 (Mus musculus)
Pain Link Frequency Relevance Heat
psoriasis 44 78.20 Quite High
chemokine 17 75.84 Quite High
rheumatoid arthritis 89 61.52 Quite High
imagery 12 60.80 Quite High
cytokine 62 51.32 Quite High
ischemia 52 50.00 Quite Low
Central nervous system 66 40.52 Quite Low
Inflammation 49 7.12 Low Low
neurotrophin 3 64 5.00 Very Low Very Low Very Low
Multiple sclerosis 49 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Cancer 421 99.46 Very High Very High Very High
Breast Cancer 6 97.64 Very High Very High Very High
Systemic Sclerosis 34 96.40 Very High Very High Very High
Infection 388 95.80 Very High Very High Very High
Acquired Immune Deficiency Syndrome Or Hiv Infection 32 94.96 High High
Adhesions 21 93.00 High High
Disease 82 92.48 High High
Viral Infection 104 91.60 High High
Cytomegalovirus Infection 449 89.32 High High
Sclerosis 1 84.64 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
negative cells were found to express Oct4, it appeared that once CD29 expression occurred on these CD24(hi) cells the number of Oct4-expressing cells was reduced (Fig. 6, upper panel, histogram on the right).
Gene_expression (expression) of CD29 in upper
1) Confidence 0.42 Published 2011 Journal PLoS ONE Section Body Doc Link PMC3020957 Disease Relevance 0.17 Pain Relevance 0
HF diet activated expression of genes of endothelium integrins (Itga5, Itga6, Itgam, Itgb1, Itgb2) which participate in cell-matrix interactions.
Gene_expression (expression) of Itgb1 in endothelium
2) Confidence 0.42 Published 2009 Journal Lipids Health Dis Section Body Doc Link PMC2674043 Disease Relevance 0.32 Pain Relevance 0
Although CD24(hi)CD29(?)
Gene_expression (Although) of CD29
3) Confidence 0.37 Published 2011 Journal PLoS ONE Section Body Doc Link PMC3020957 Disease Relevance 0.16 Pain Relevance 0
In these studies, we observed a significant decrease in the number of CD24(hi)CD29(?)
Gene_expression (number) of CD29
4) Confidence 0.32 Published 2011 Journal PLoS ONE Section Body Doc Link PMC3020957 Disease Relevance 0.08 Pain Relevance 0
Based on the available literature, it is believed that CD24(hi)CD29(?)
Gene_expression (believed) of CD29
5) Confidence 0.32 Published 2011 Journal PLoS ONE Section Body Doc Link PMC3020957 Disease Relevance 0.56 Pain Relevance 0
In this study, we demonstrated that CD24(hi)CD29(?)
Gene_expression (demonstrated) of CD29
6) Confidence 0.32 Published 2011 Journal PLoS ONE Section Body Doc Link PMC3020957 Disease Relevance 0.14 Pain Relevance 0
Using these methods, we were able to identify 3 distinct cellular populations; CD24(hi)CD29(?)
Gene_expression (able) of CD29
7) Confidence 0.32 Published 2011 Journal PLoS ONE Section Body Doc Link PMC3020957 Disease Relevance 0.51 Pain Relevance 0
The bottom panel of Fig. 4 shows a representative contour plot prepared from control mice, depicting three distinct cellular subsets, CD24(hi)CD29(?)
Gene_expression (subsets) of CD29
8) Confidence 0.32 Published 2011 Journal PLoS ONE Section Body Doc Link PMC3020957 Disease Relevance 0.06 Pain Relevance 0
Consistent with these findings, we observed that CD24(hi)CD29(?)
Gene_expression (observed) of CD29
9) Confidence 0.32 Published 2011 Journal PLoS ONE Section Body Doc Link PMC3020957 Disease Relevance 0.57 Pain Relevance 0
Control tumor sections did not show the expression of CD29.
Gene_expression (expression) of CD29 associated with cancer
10) Confidence 0.29 Published 2010 Journal Aging (Albany NY) Section Body Doc Link PMC3006022 Disease Relevance 0.47 Pain Relevance 0
By FACS we observed that nearly all G-2 cells express the stemness-related markers CD29 (integrin beta 1) [30] (Figure 7A) and CD44 (hyaluronate receptor) [31] (Figure 7B).
Gene_expression (express) of integrin beta 1
11) Confidence 0.20 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2920333 Disease Relevance 0.24 Pain Relevance 0
By FACS we observed that nearly all G-2 cells express the stemness-related markers CD29 (integrin beta 1) [30] (Figure 7A) and CD44 (hyaluronate receptor) [31] (Figure 7B).
Gene_expression (express) of CD29
12) Confidence 0.20 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2920333 Disease Relevance 0.24 Pain Relevance 0
These cells express CD29, CD105 and are negative for CD34 and CD45.
Gene_expression (express) of CD29
13) Confidence 0.14 Published 2008 Journal J Transl Med Section Body Doc Link PMC2533293 Disease Relevance 0 Pain Relevance 0
Flow cytometry showed the MSCs had no expressions of CD34, CD45 and HLA-DR, but high expressions of CD29 and CD44.
Gene_expression (expressions) of CD29
14) Confidence 0.09 Published 2011 Journal International Journal of Medical Sciences Section Body Doc Link PMC3020395 Disease Relevance 0.76 Pain Relevance 0.06
Using differential display technology, enhanced expression of extracellular matrix molecules like fibronectin receptor, fibrosin, nexin-1 and insulin-like growth factor binding protein (IGFBP)-5 was demonstrated in SSc.
Gene_expression (expression) of fibronectin receptor in extracellular matrix associated with systemic sclerosis
15) Confidence 0.01 Published 2009 Journal Mediators of Inflammation Section Body Doc Link PMC2768824 Disease Relevance 1.10 Pain Relevance 0.13

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox